Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of Rituximab in Acute Cellular Rejection With B-cell Infiltrates in Renal Transplant Patients - Randomized Placebo Controlled Double Blind Trial

NCT01117662 is registered in ClinicalTrials.gov with Hannover Medical School as lead sponsor.

NCT NCT01117662
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01117662 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of Rituximab in Acute Cellular Rejection With B-cell Infiltrates in Renal Transplant Patients - Randomized Placebo Controlled Double Blind Trial
Lead sponsor
Hannover Medical School
Phase
Phase 3
Overall status
Terminated
Start date
May 31, 2012
Completion date
August 23, 2016
Enrollment
13 (actual)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

acute rejection